[go: up one dir, main page]

UY29991A1 - SALTS, PROMARMS AND FORMULATIONS OF 1- (5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO (2,3-D) PIRIMIDIN-5-CARBON) -2-METOXI-PHENIL) -3- (2,4 -DICLORO-PHENIL) -UREA - Google Patents

SALTS, PROMARMS AND FORMULATIONS OF 1- (5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO (2,3-D) PIRIMIDIN-5-CARBON) -2-METOXI-PHENIL) -3- (2,4 -DICLORO-PHENIL) -UREA

Info

Publication number
UY29991A1
UY29991A1 UY29991A UY29991A UY29991A1 UY 29991 A1 UY29991 A1 UY 29991A1 UY 29991 A UY29991 A UY 29991A UY 29991 A UY29991 A UY 29991A UY 29991 A1 UY29991 A1 UY 29991A1
Authority
UY
Uruguay
Prior art keywords
phenil
promarms
isopropil
pirimidin
metoxi
Prior art date
Application number
UY29991A
Other languages
Spanish (es)
Inventor
Franzanne Vreeland
Ravi Mysore Shanker
Douglas Alan Lorenz
Susan Deborah Lagreca
Feng Gluo
Tracy Lee Boyden
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY29991A1 publication Critical patent/UY29991A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La invención se refiere a compuestos de la fórmula o una sal farmacéuticamente aceptable, profármaco o hidratos de los mismos. La invención también se refiere a composiciones farmacéuticas que contienen los compuestos de fórmula 1 y a métodos para tratar trastornos hiperproliferativos en un mamífero por medio de la ad ministración de los compuestos de fórmula 1.The invention relates to compounds of the formula or a pharmaceutically acceptable salt, prodrug or hydrates thereof. The invention also relates to pharmaceutical compositions containing the compounds of formula 1 and to methods for treating hyperproliferative disorders in a mammal by means of the administration of the compounds of formula 1.

UY29991A 2005-12-09 2006-12-06 SALTS, PROMARMS AND FORMULATIONS OF 1- (5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO (2,3-D) PIRIMIDIN-5-CARBON) -2-METOXI-PHENIL) -3- (2,4 -DICLORO-PHENIL) -UREA UY29991A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US74907005P 2005-12-09 2005-12-09

Publications (1)

Publication Number Publication Date
UY29991A1 true UY29991A1 (en) 2007-07-31

Family

ID=38123252

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29991A UY29991A1 (en) 2005-12-09 2006-12-06 SALTS, PROMARMS AND FORMULATIONS OF 1- (5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO (2,3-D) PIRIMIDIN-5-CARBON) -2-METOXI-PHENIL) -3- (2,4 -DICLORO-PHENIL) -UREA

Country Status (8)

Country Link
AR (1) AR058293A1 (en)
DO (1) DOP2006000271A (en)
GT (1) GT200600496A (en)
NL (1) NL2000337A1 (en)
PE (1) PE20071037A1 (en)
TW (1) TW200733965A (en)
UY (1) UY29991A1 (en)
WO (1) WO2007066189A2 (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090143423A1 (en) * 2007-10-19 2009-06-04 Abbott Gmbh & Co. Kg Solid dispersion product containing n-aryl urea-based compound
AU2008313622A1 (en) * 2007-10-19 2009-04-23 Abbott Gmbh & Co. Kg Solid dispersion product of N-aryl urea-based drugs
JP5819195B2 (en) * 2008-10-16 2015-11-18 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Fusion ring heteroaryl kinase inhibitors
WO2011082273A2 (en) 2009-12-30 2011-07-07 Arqule, Inc. Substituted pyrrolo-aminopyrimidine compounds
BR112012032248A2 (en) * 2010-06-23 2016-09-13 Metabolex Inc 5-ethyl-2- {4 - [- 4- (-4-tetrazol-1-yl-phenoxymethyl) -thiazol-2-yl] -piperidin-1-yl} -pyrimidine compositions
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
MX370814B (en) 2011-09-02 2020-01-08 Univ California Substituted pyrazolo[3,4-d]pyrimidines and uses thereof.
US20140004192A1 (en) * 2012-04-13 2014-01-02 Ziopharm Oncology, Inc. Pharmaceutical formulations of indibulin and uses thereof
PE20190736A1 (en) 2012-06-13 2019-05-23 Incyte Holdings Corp TRICICLIC COMPOUNDS REPLACED AS INHIBITORS OF THE RECEIVER OF THE FIBROBLAST GROWTH FACTOR (FGFR)
WO2014026125A1 (en) 2012-08-10 2014-02-13 Incyte Corporation Pyrazine derivatives as fgfr inhibitors
RU2015115631A (en) 2012-09-26 2016-11-20 Дзе Риджентс Оф Дзе Юниверсити Оф Калифорния MODULATION IRE1
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
KR102269032B1 (en) 2013-04-19 2021-06-24 인사이트 홀딩스 코포레이션 Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
ES2895769T3 (en) 2015-02-20 2022-02-22 Incyte Corp Bicyclic heterocycles as FGFR inhibitors
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MA41551A (en) 2015-02-20 2017-12-26 Incyte Corp BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS
CN107722012B (en) * 2016-08-11 2020-05-29 斯福瑞（南通）制药有限公司 Process for preparing 4-chloro-7H-pyrrolo [2,3-d ] pyrimidines
AR111960A1 (en) 2017-05-26 2019-09-04 Incyte Corp CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION
SI3788047T1 (en) 2018-05-04 2024-11-29 Incyte Corporation Solid forms of an fgfr inhibitor and processes for preparing the same
SG11202010882XA (en) 2018-05-04 2020-11-27 Incyte Corp Salts of an fgfr inhibitor
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
US11591329B2 (en) 2019-07-09 2023-02-28 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US11607416B2 (en) 2019-10-14 2023-03-21 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
WO2021113462A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2022221170A1 (en) 2021-04-12 2022-10-20 Incyte Corporation Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent
WO2022261159A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2022261160A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
JP2025015449A (en) * 2023-07-18 2025-01-30 信越化学工業株式会社 Composition for solid dispersion, solid dispersion, and method of manufacturing solid dispersion

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE364374T1 (en) * 1997-08-11 2007-07-15 Pfizer Prod Inc SOLID PHARMACEUTICAL DISPERSIONS WITH INCREASED BIOAVAILABILITY
UA80171C2 (en) * 2002-12-19 2007-08-27 Pfizer Prod Inc Pyrrolopyrimidine derivatives

Also Published As

Publication number Publication date
DOP2006000271A (en) 2007-08-15
PE20071037A1 (en) 2007-11-19
AR058293A1 (en) 2008-01-30
NL2000337A1 (en) 2007-06-12
GT200600496A (en) 2007-07-17
TW200733965A (en) 2007-09-16
WO2007066189A3 (en) 2008-08-14
WO2007066189A2 (en) 2007-06-14

Similar Documents

Publication Publication Date Title
UY29991A1 (en) SALTS, PROMARMS AND FORMULATIONS OF 1- (5- (4-AMINO-7-ISOPROPIL-7H-PIRROLO (2,3-D) PIRIMIDIN-5-CARBON) -2-METOXI-PHENIL) -3- (2,4 -DICLORO-PHENIL) -UREA
ECSP055867A (en) PIRROLOPIRIMIDINE DERIVATIVES
EA201000805A1 (en) BIS- (SULFONILAMINO) DERIVATIVES IN THERAPY 066
AR056873A1 (en) DERIVATIVES OF PIRAZOLOPIRIMIDINAS AS QUINASA INHIBITORS OF CYCLINE DEPENDENTS, PHARMACEUTICAL COMPOSITIONS
AR106237A2 (en) HETEROCYCLIC INHIBITORS OF ASPARTIL PROTEASA, ITS PHARMACEUTICALLY ACCEPTABLE SALTS
NO20085060L (en) Triazole pyrazine derivatives useful as anti-cancer agents
EA201070588A1 (en) DERIVATIVES 1,2,3-TRIAZOLE FOR USE AS STAROIL-COA DESSATRASE AS AN INHIBITORS
CR10027A (en) NEW DERIVATIVES OF FUSIONATED PIRROL
ECSP014097A (en) USEFUL THIOPHEN DERIVATIVES AS ANTI-TARGET AGENTS
CR10636A (en) QUINASE INHIBITOR
UY29322A1 (en) CXCR2 INHIBITORS
CR10710A (en) CERTAIN SUBSTITUTED AMIDAS, METHOD OF ELABORATION AND METHOD OF USE OF THE SAME
ECSP099663A (en) DERIVATIVES AND COMPOSITIONS THAT INCLUDE ISOINDOLIN 4'-O-SUBSTITUTED AND METHODS TO USE THE SAME
ECSP066383A (en) DERIVATIVES OF 5-PHENYL-4-METHYL-TIAZOL-2-IL-AMINA AS INHIBITORS OF KINASA ENZYMES PHOSFATIDILINOSITOL 3 (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY ROUTES
UY32156A (en) SUBSTITUTED DERIVATIVES OF THE N2 - [1- (5 - FLUOROPIRIMIDIN -2-IL) ETIL] - N4 - (1-METHYL - 1H-IMIDAZOL - 4 - IL)) - PYRIMIDINE - 2,4 - DIAMINES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS , PREPARATION PROCESS, COMPOSITIONS CONTAINING THEM AND APPLICATIONS.
ECSP034744A (en) N-REPLACED N-REPLACED NMDA / NR2B ANTAGONISTS
EA200870448A1 (en) PREPARATION OF 1,2,4-TRIAZOLES
UY30460A1 (en) THERAPEUTIC COMPOUNDS
CO5580767A2 (en) INDAZOL COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS TO INHIBIT PROTEINKINES AND PROCEDURES FOR USE
ATE397605T1 (en) NEBIVOLOL AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS, PRODUCTION PROCESS AND PHARMACEUTICAL COMPOSITIONS OF NEBIVOLOL
ECSP088700A (en) 4-PHENYL-TIAZOL-5-CARBOXILIC ACIDS AND 4-PHENYL-TIAZOL-5-CARBOXILIC ACIDS AS INHIBITORS OF THE PLK1
PA8582101A1 (en) INDOLES REPLACED IN POSITION 2,4
AR056574A1 (en) PIRAZOL DERIVATIVES, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND USE PROCEDURES
AR070661A1 (en) 1,2,4- TRISUSTITUTED TRIAZOLS
AR057885A1 (en) ACID 1- (1- (2- ETOXIETIL) - 1- ETIL-7- (4- METHYLPIRIDIN -2- ILAMINO) - 1H PIRAZOLO (4,3-D) PIRIMIDIN -5- IL) PIPERIDINE -4- CARBOXYL AND SALTS OF THE SAME. PHARMACEUTICAL COMPOSITIONS.

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20161213